StockData
Silexion Therapeutics Corp logo

Silexion Therapeutics Corp (SLXN) stock

SLXNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as SLXNW
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.15+0.00 (0.00%)

Close on Oct 19, 2026Market cap $904.58KP/E –Yield –

Silexion Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Silexion Therapeutics

Silexion Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Silexion Therapeutics figures

See a number that looks wrong?